1',2'-Dihydrospiro[cyclopentane-1,3'-indole]-5'-carbonitrile

Catalog No.: 
ACJBUL131
CAS No.: 
2060053-36-1
Molecular Formula: 
C13H14N2
Molecular Weight: 
198.27
1',2'-Dihydrospiro[cyclopentane-1,3'-indole]-5'-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$169.00InquiryInquiry
250mg95%$327.00InquiryInquiry
1g95%$1046.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1',2'-Dihydrospiro[cyclopentane-1,3'-indole]-5'-carbonitrile
IUPAC Namespiro[cyclopentane-1,3'-indoline]-5'-carbonitrile
MDL No.MFCD30499957
Molecular FormulaC13H14N2
Molecular Weight198.27
SMILESN#CC1=CC(C23CCCC2)=C(NC3)C=C1
InChI KeyBTBCTYZEVRDFGN-UHFFFAOYSA-N
SynonymSpiro[cyclopentane-1,3'-[3H]indole]-5'-carbonitrile, 1',2'-dihydro-
CAS No.2060053-36-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJBUL131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJZPD175 route compound structure diagram
    ACJZPD1751160247-93-7In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACJBUL131 route product structure diagram
    ACJBUL1312060053-36-1
Inquiry

2. ACJBUL131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJBUL131 route product structure diagram
    ACJBUL1312060053-36-1
Inquiry

3. ACJBUL131 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJBUL131 route product structure diagram
    ACJBUL1312060053-36-1
Inquiry

Comments (0)